Year: 2023

MARIETTA, Ga., Dec. 28, 2023 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that its outstanding 95,000 shares of Series B Convertible Preferred Stock (the “Preferred Stock”), together with any accrued dividends, were automatically converted into shares of the Company’s Common Stock on December 22, 2023, in accordance with the Preferred Stock terms set forth in the Company’s Articles of Incorporation. As a result of this conversion, approximately 30 million shares of Common Stock have been added to the Company’s share count. The conversion of the shares ends the dividend accrual associated with the Preferred Stock. Commenting on the conversion, MIMEDX Chief Executive Officer, Joseph H. Capper stated, “Today marks an important milestone in our journey to improve MIMEDX’s financial...

Fully funded 7.9 EH/s, increasing self-mining capacity by 58% Building 3 at the Lake Mariner facility now fully operational Planning for additional growth with construction of Building 4 already underway Expansion of existing HPC project supporting generative AI planned for 2024 EASTON, Md., Dec. 28, 2023 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), which owns and operates vertically integrated, domestic Bitcoin mining facilities powered by more than 91% zero-carbon energy, today provided a business update. Key HighlightsFully funded 7.9 EH/s expansion, increasing self-mining capacity by 58%.Building 3 at the Lake Mariner facility is operational and ready for delivery, installation and energization of new miners.Estimated deployment date of February 1, 2024, for all 18,500 BITMAIN Antminer...

ACTON, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced the pricing of a public offering of 2,692,308 shares of the Company’s common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 2,692,308 shares of common stock at a combined offering price of $1.30 per share (or pre-funded warrant in lieu thereof) and associated warrant. The warrants will have an exercise price of $1.30 per share and will be immediately exercisable upon issuance for a period of five years following the date of issuance. The closing of the offering is expected to occur on or about January 2, 2024, subject to the satisfaction...

TORONTO, Dec. 28, 2023 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments ) today announced the final December 2023 cash distributions and annual 2023 reinvested capital gains distributions for the AGF Investments ETFs listed on the Toronto Stock Exchange or NEO Exchange. Unitholders of record of an AGF Investments ETF on December 29, 2023 will receive (i) the actual 2023 reinvested capital gains distributions payable in respect of that AGF investments ETF on December 29, 2023; and (ii) the actual December 2023 cash distributions payable in respect of that AGF Investments ETF on January 5, 2024. The actual taxable amounts for 2023, including the tax characteristics, will be reported in early 2024. The annual reinvested capital gains distributions generally represent realized capital gains within the AGF Investments ETFs and...

Bullet Blockchain’s subsidiary, First Bitcoin Capital LLC, continues to pursue unlicensed violators of Bullet Blockchain’s Intellectual Property RENO, NV, Dec. 28, 2023 (GLOBE NEWSWIRE) — via NewMediaWire - Bullet Blockchain, Inc. (“BULT” or the “Company”) (OTC: BULT), a pioneering software development and SaaS company at the forefront of blockchain and Bitcoin ATM technologies, proudly announces a significant milestone: preliminary 2023 fourth quarter gross revenue will likely exceed $740,000. “We delivered a solid fourth quarter which is reflective of our acquisition strategy and improved Bitcoin pricing. While the upcoming Bitcoin halving and anticipated trading of a Bitcoin ETF is lifting the market in the short term, we are seeing the cryptocurrency environment continue to improve and anticipated demand for our products and...

SAN DIEGO, Dec. 28, 2023 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO), today announced significant upgrades to its pipeline for analysis of optical genome mapping (OGM) data in its VIA™ software for applications in constitutional genetic disease. The latest analysis pipeline, Bionano Solve 3.8.1, enhances the sensitivity and specificity for structural variation (SV) detection from OGM data, which, when combined with copy number variant (CNV) analysis capabilities introduced in July 2023, further advance OGM’s leadership in variant detection. Together with the enhanced performance for SV and CNV calling, VIA software now enables the most comprehensive visualization, interpretation and reporting of SVs and CNVs from OGM data in constitutional genetic disease research. Features of the VIA software that apply to...